Twist Bioscience Corp (TWST): Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
Twist Bioscience (TWST) narxlarining dinamikasi AI boshqaruvidagi robotlar yordamida DNK ketma-ketliklarini yaratishni avtomatlashtiruvchi kompaniyaning rivojlanishini aks ettiradi. Biznes sintetik biologiya sohasidagi yetakchilikka asoslangan bo'lib, agro va biotexnologiya sektorlariga hamyonbop gen sintezini taklif etadi. Kremniy chop etish texnologiyalari tufayli firma laboratoriyalar uchun asosiy bo'g'inga aylandi va yakka tartibdagi uzoq muddatli qarzdorlikning kapitalga nisbati 0.18 darajasida turibdi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_TWST_-_Twist-Bioscience_-_Long-Term-Debt-to-Capital "TWST: Twist Bioscience Inc Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
Twist Bioscience (TWST) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Twist Bioscience|TWST - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti twistbioscience.com|TWST - Kompaniya qarzlari|Sof aktivlarga qarzlar Twist Bioscience, Inc.|TWST - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Twist Bioscience
Fundamental baholash:TWST Twist Bioscience Inc
Kremniy platformalaridagi diversifikatsiyalashgan DNK sintezi Twist Bioscience (TWST) uchun sanoat risklarini minimallashtiradi, biroq kapitaldagi uzoq muddatli qarz yuklamasi bir yildan ortiq muddatli majburiyatlarning kapitalga nisbati orqali ushbu strategiyaning barqarorligini baholash imkonini beradi. Ushbu ko'rsatkichning tahlili biznes rivojlanishining qarz resurslariga haqiqiy bog'liqligini ochib beradi va kompaniyaning moliyaviy mustaqilligiga tahdid solmasdan yoki aksiyadorlar qiymatini pasaytirmasdan kengayishni moliyalashtirish qobiliyatini tasdiqlaydi.
Asosiy raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group QGEN|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Isis Pharmaceuticals (IONS)|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|RNA - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CRISPR Therapeutics CRSP|GeneDx Holdings (WGS) - Uzoq muddatli kreditlarning kapitalga nisbati|RARE (Ultragenyx Pharma) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Beam Tx (BEAM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|SRPT: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TXG|NTLA (Intellia Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Stoke Therapeutics Inc STOK|Uzoq muddatli qarzning o'z kapitaliga nisbati BioLife Corp (BLFS)|WVE - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Maze Therapeutics Inc (MAZE)|SION - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Prime Medicine (PRME) - Uzoq muddatli qarzning kapitalga nisbati|Taysha Gene Therapies Inc (TSHA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|QURE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati MGTX|REGENXBIO Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati SLDB (solidbio.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati OCGN|Uzoq muddatli qarzdorlikning kapitalga nisbati Pacific Biosciences of California, Inc. PACB|BNTC: Uzoq muddatli qarzning kapitalga nisbati|DSGN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Rocket Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati|4dmoleculartherapeutics.com (FDMT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati LXEO (Lexeo Therapeutics Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati KRRO|Uzoq muddatli qarzning o'z kapitaliga nisbati Editas EDIT|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Silence Therapeutics Corp (SLN)|ProQR Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Codexis Inc CDXS|SGMO (Sangamo Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Nautilus Biotechnology (NAUT) - Uzoq muddatli majburiyatlarning kapitalga nisbati|MGX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati Precision BioSciences Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati GBIO|Uzoq muddatli qarzning o'z kapitaliga nisbati BOLD|XCUR (Exicure, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati imunon.com IMNN|Uzoq muddatli qarzning o'z kapitaliga nisbati Phio Pharmaceuticals Corp. (PHIO)|Uzoq muddatli kreditlarning kapitalga nisbati Mustang Bio Inc MBIO|TransCode (RNAZ) - Uzoq muddatli qarzning kapitalga nisbati|BNGO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Applied DNA Sciences, Inc.|bluebird bio Inc. (BLUE) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|IPA (ImmunoPrecise Antibodies Ltd) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Omega Therapeutics Corp (OMGA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems|Uzoq muddatli kreditlarning kapitalga nisbati regulusrx.com RGLS|Syros Pharmaceuticals, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Telesis Bio Inc. TBIO|Uzoq muddatli qarzning kapitalga nisbati TCON (TRACON)|UBX: Uzoq muddatli qarzdorlikning kapitalga nisbati